Physician
Pediatric and Adolescent Healthcare Associates of Waxahachie, P. A.
Pediatric and Adolescent Healthcare Associates of Waxahachie, P. A. was paid $484K by Medicaid between Jan 2020 and Dec 2024, across 48 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 29% of everything it billed.
33Billing provider infoPEDIATRIC AND ADOLESCENT HEALTHCARE ASSOCIATES OF WAXAHACHIE, P. A.
WAXAHACHIE, TX 75165
WAXAHACHIE, TX 75165
33aNPI1083693782assigned 01/11/2006
33bProvider typePediatrics Physician
28Total paid$484K
24GClaims77,256
24DCodes billed48
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#513 of 1,136
Median peer was paid$329K
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 3,172 | $15K | |
| 2021 | 20,015 | $30K | |
| 2022 | 18,309 | $40K | |
| 2023 | 20,703 | $206K | |
| 2024incomplete | 15,057 | $192K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 29% | 2,885 | 2,768 | $142K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 16,015 | 14,066 | $105K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.4% | 2,222 | 2,207 | $36K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.7% | 11,984 | 5,475 | $32K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.0% | 1,787 | 1,713 | $29K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.6% | 364 | 352 | $27K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.6% | 1,831 | 1,820 | $27K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.5% | 2,552 | 2,421 | $27K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.7% | 1,694 | 1,678 | $23K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 4,515 | 4,303 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 5,191 | 2,493 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 178 | 175 | $5K |
36 more codes
| 99429 | <1% | 1,016 | $5K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 88 | $3K |
| 87634 | <1% | 46 | $2K | |
| 99381 | <1% | 191 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 82 | $1K |
| 87807 | <1% | 606 | $946.00 | |
| 90461 | <1% | 5,388 | $559.22 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $441.09 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,405 | $375.36 |
| 90619 | <1% | 359 | $311.18 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 112 | $278.44 |
| 83655 | <1% | 164 | $194.36 | |
| 92551 | <1% | 782 | $176.76 | |
| 85018 | <1% | 417 | $94.19 | |
| 97802 | <1% | 4,190 | $6.19 | |
| 90677 | <1% | 430 | $1.94 | |
| 90698 | 0% | 1,683 | $0.00 | |
| 90651 | 0% | 783 | $0.00 | |
| 90688 | 0% | 893 | $0.00 | |
| 90680 | 0% | 1,153 | $0.00 | |
| 90744 | 0% | 778 | $0.00 | |
| 90696 | 0% | 219 | $0.00 | |
| 90716 | 0% | 810 | $0.00 | |
| 36416 | 0% | 34 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 128 | $0.00 |
| 90656 | 0% | 66 | $0.00 | |
| 94761 | 0% | 13 | $0.00 | |
| 90707 | 0% | 802 | $0.00 | |
| 90670 | 0% | 1,318 | $0.00 | |
| 99173 | 0% | 761 | $0.00 | |
| 90633 | 0% | 809 | $0.00 | |
| 90734 | 0% | 267 | $0.00 | |
| 90715 | 0% | 182 | $0.00 | |
| 90713 | 0% | 12 | $0.00 | |
| 81002 | 0% | 25 | $0.00 | |
| 90700 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTRENGTH, MARY (OWNER)